Probi reports on AGM 2018.
NORDIC BUSINESS REPORT-May 3, 2018-Probi reports on AGM 2018
(C)2018 M2 COMMUNICATIONS http://www.m2.com
Probi AB (STO:PROB), a Swedish bioengineering company, reported on Wednesday that the Annual General Meeting, held on2 May 2018, approved the annual report and resolved, in accordance with the board of directors' proposal, that no dividend should be declared for the financial year 2017.
The Annual General Meeting discharged the Board members and the CEO from liability for the financial year 2017.
Also, the AGM resolved that the board shall consist of seven members without any deputies. Scott Bush, Charlotte Hansson, Anna Malm Bernsten, Jan Nilsson, Jonny Olsson and Jean-Yves Parisot were re-elected as board members, with Parisot re-elected as chairman of the board. Irene Corthesy Malnoe was elected as a new board member.
Regarding the board fees, the AGM determined a total fees of SEK1,600,000, whereof SEK400,000 is to the chairman and SEK200,000 to each of the other members. In addition, fee for committee work was determined to SEK70,000 to the chairman of the audit committee and SEK40,000 to the other members and SEK30,000 to chairman of the remuneration committee and SEK20,000 to the other members.
In addition, the AGM newly elected the registered public accounting firm Ernst & Young AB, which had informed that Peter Gunnarsson should be the auditor in charge.
The board's proposal regarding guidelines for remuneration of senior executives was approved.
Furthermore, at the AGM, the board was authorised, in accordance with its proposal, for the period until the next AGM and, on one or several occasions, to resolve on repurchase and transfers of own shares. The board was also authorised, in accordance with its proposal, for the period until the next AGM and, on one or several occasions, to resolve on the issue of a maximum of1,164,412 shares.
Finally, a nomination committee was appointed by the Annual General Meeting, ahead of the Annual General Meeting 2019, consisting of Heinz-Jurgen Bertram (Symrise), Jannis Kitsakis (Fourth Swedish National Pension Fund), Marianne Flink (Swedbank Robur funds) and Bengt Jeppsson (Professor, Surgical Faculty, Lund University, representing the minor shareholders).
Probi delivers effective and well -documented probiotics, with proven health benefits based on scientific research.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||annual general meeting|
|Publication:||Nordic Business Report|
|Date:||May 3, 2018|
|Previous Article:||GN Store Nord initiates new DKK1,000m share buyback programme.|
|Next Article:||Troax's profit up in Q1 2018.|